Category
You are here: Home
Screening
The European Lab Automation Conference and Exhibition 2012
Staying abreast of the latest advances in technology and ensuring that the most effective, up-to-date automation techniques are being employed can be challenging. Attending conferences and exhibitions throughout the year provides scientists not only the opportunity to share their experiences and to network with researchers in their field, but delegates can also discuss their challenges with equipment manufacturers who can often help to tailor a solution to meet their automation needs. more02.05.2012SLAS Now Accepting Abstract Submissions for Presentations at 2nd SLAS Conference and Exhibition
The Society for Laboratory Automation and Screening (SLAS) is now accepting abstract submissions for podium and poster presentations at SLAS2013, the Second Annual SLAS Conference and Exhibition, January 12-16, at the Gaylord Palms Resort and Convention Center in Orlando, FL, USA. more20.04.2012Roche Steps Back from Illumina Acquisition
F. Hoffman-La Roche dropped its bid to buy the gene-sequencing leader Illumina this week after Illumina's shareholders made it clear at the company's annual meeting that the terms were inadequate. Roche had made a $51 per share tender offer for San Diego-based Illumina, but will allow the offer to expire today. Late last year Roche offered $40/share for Illumina, eventually increasing the offer to $44.50 and then $51 per share. more12.04.2012Roche Ratchets up the Pressure on Illumina
If there is an axiom to describe F. Hoffman-La Roche, it is that what Roche wants, it gets. The Swiss-based multinational pharmaceutical company bought a majority stake in Genentech in 1990 and decided in 2008 that they wanted the rest of the company. In July 2008, Roche offered $43.7 billion for the 44% of Genentech that it did not already own. Roche went hostile in January of 2009, cutting its bid to $42.5 billion, but eventually relented and paid $46.8 billion in March 2009. The final price represented a 10% premium over the January bid. more18.03.2012Novel Nanopore 'Strand Sequencing' Technique and a Disposable DNA Sequencing Device
The new nanopore 'strand sequencing' technique and the high performance electronic devices GridION and MinION were presented by Oxford Nanopore Technologies last month. The company intends to commercialize the two devices directly to customers within 2012. more
Droplet-based Microfluidics: Sensitive Detection of Rare Mutations
In oncology, the success of treatment against a specific cancer is linked to the ability to detect tumor cells as early as possible: early diagnostics are essential part in the fight against cancer. In that respect, there is a need for sensitive methods to find traces of cancer biomarkers in samples coming from patients. A vision for the future of cancer diagnostics would be based on the analysis of bodily fluids to find these biomarkers. A high sensitivity is there a strong pre-requisite to be able to distinguish genetic alterations at the level of traces in such samples. more25.01.2012Qiagen to Provide siRNA Libraries in Labcyte Acoustically Compatible Microplates
Qiagen and Labcyte, the developer of acoustic liquid handling, announced that Qiagen FlexiPlate siRNA reagent libraries are now available in Labcyte Echo qualified microplates. These microplates enable researchers to use the Echo liquid handler to miniaturize the transfer of small interfering RNA reagents. more16.01.2012SLAS New Product Award: Designation at First Annual SLAS Conference and Exhibition
SLAS2012: In an industry where change is the only constant, companies need to stay ahead of the curve by continually deploying new technology that dramatically impacts the world of laboratory science. Through the New Product Award (NPA) Designation, the Society for Laboratory Automation and Screening (SLAS) will recognize up to three companies presenting new products at SLAS2012, February 4-8, San Diego Convention Center, San Diego, CA, USA. more
Killing me Softly: How the Bioweapon Ricin Kills
A key protein that controls how the deadly plant poison and bioweapon ricin kills, has finally been identified by researchers at the Institute of Molecular Biotechnology in Vienna, Austria. The discovery was made using a revolutionary technology that combines stem cell biology and modern screening methods, and reported today (Friday 2 December 2011) in the scientific journal Cell Stem Cell. more23.11.2011Karolinska Institutet: New Method for Counting Molecules Developed
Researchers at the Swedish medical university Karolinska Institutet have developed a new method for counting molecules. Quantifying the amounts of different kinds of RNA and DNA molecules is a fundamental task in molecular biology as these molecules store and transfer the genetic information in cells. Thus, improved measurement techniques are crucial for understanding both normal and cancer cells. more- Legal
- Help
- Participate
- Related Publications